{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T23:56:49Z","timestamp":1790035009426,"version":"4.0.1"},"reference-count":49,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2018,4,5]],"date-time":"2018-04-05T00:00:00Z","timestamp":1522886400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Lyla Nsouli Foundation"},{"name":"With Purpose Foundation"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0193565","type":"journal-article","created":{"date-parts":[[2018,4,6]],"date-time":"2018-04-06T00:20:19Z","timestamp":1522974019000},"page":"e0193565","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":35,"title":["IL-13 receptors as possible therapeutic targets in diffuse intrinsic pontine glioma"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8666-3152","authenticated-orcid":true,"given":"Noah E.","family":"Berlow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew N.","family":"Svalina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Quist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teagan P.","family":"Settelmeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktor","family":"Zherebitskiy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari","family":"Kogiso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchen","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia E.","family":"Hawkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9256-947X","authenticated-orcid":true,"given":"Esther","family":"Hulleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Nan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4717-0408","authenticated-orcid":true,"given":"Sakir H.","family":"Gultekin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2505-7487","authenticated-orcid":true,"given":"Charles","family":"Keller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,4,5]]},"reference":[{"issue":"8","key":"ref1","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1200\/JCO.2005.04.6599","article-title":"Advances toward an understanding of brainstem gliomas","volume":"24","author":"SS Donaldson","year":"2006","journal-title":"J Clin Oncol"},{"issue":"3","key":"ref2","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S1470-2045(06)70615-5","article-title":"Diffuse brainstem glioma in children: critical review of clinical trials","volume":"7","author":"D Hargrave","year":"2006","journal-title":"The Lancet Oncology"},{"issue":"10","key":"ref3","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1093\/neuonc\/nor092","article-title":"Treatment of high-grade glioma in children and adolescents","volume":"13","author":"TJ MacDonald","year":"2011","journal-title":"Neuro-oncology"},{"issue":"5","key":"ref4","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/pbc.24923","article-title":"A diffuse intrinsic pontine glioma roadmap: guiding research toward a cure","volume":"61","author":"SE Smith","year":"2014","journal-title":"Pediatric blood & cancer"},{"issue":"1","key":"ref5","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/BF00263825","article-title":"Management of pediatric pontine gliomas","volume":"7","author":"IA Langmoen","year":"1991","journal-title":"Childs Nerv Syst"},{"issue":"2","key":"ref6","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/ana.410270212","article-title":"Hyperfractionated radiotherapy for children with brainstem gliomas: a pilot study using 7,200 cGy","volume":"27","author":"RJ Packer","year":"1990","journal-title":"Ann Neurol"},{"issue":"3","key":"ref7","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s11060-005-6747-7","article-title":"The treatment of high grade gliomas and diffuse intrinsic pontine tumors of childhood and adolescence: a historical\u2014and futuristic\u2014perspective","volume":"75","author":"JL Finlay","year":"2005","journal-title":"JNeurooncol"},{"issue":"16","key":"ref8","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.1200\/JCO.2002.04.109","article-title":"Preradiation chemotherapy in primary high-risk brainstem tumors: phase II study CCG-9941 of the Children&apos;s Cancer Group","volume":"20","author":"MT Jennings","year":"2002","journal-title":"J Clin Oncol"},{"issue":"3","key":"ref9","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF02341155","article-title":"High-dose multi-agent chemotherapy followed by bone marrow &apos;rescue&apos; for malignant astrocytomas of childhood and adolescence","volume":"9","author":"JL Finlay","year":"1990","journal-title":"J Neurooncol"},{"issue":"3","key":"ref10","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/(SICI)1097-0142(20000201)88:3<685::AID-CNCR27>3.0.CO;2-K","article-title":"Radiotherapy followed by high dose busulfan and thiotepa: a prospective assessment of high dose chemotherapy in children with diffuse pontine gliomas","volume":"88","author":"E Bouffet","year":"2000","journal-title":"Cancer"},{"issue":"5","key":"ref11","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1159\/000121049","article-title":"Is there a role for high-dose chemotherapy with stem cell rescue for brain stem tumors of childhood?","volume":"24","author":"IJ Dunkel","year":"1996","journal-title":"Pediatr Neurosurg"},{"issue":"4","key":"ref12","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1093\/neuonc\/noq205","article-title":"Temozolomide in the treatment of children with newly diagnosed diffuse intrinsic pontine gliomas: a report from the Children&apos;s Oncology Group","volume":"13","author":"KJ Cohen","year":"2011","journal-title":"Neuro Oncol"},{"issue":"1","key":"ref13","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ijrobp.2009.04.031","article-title":"Prospective evaluation of radiotherapy with concurrent and adjuvant temozolomide in children with newly diagnosed diffuse intrinsic pontine glioma","volume":"77","author":"R Jalali","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"ref14","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1093\/neuonc\/noq141","article-title":"Innovative Therapies for Children with Cancer pediatric phase I study of erlotinib in brainstem glioma and relapsing\/refractory brain tumors","volume":"13","author":"B Geoerger","year":"2011","journal-title":"Neuro-oncology"},{"key":"ref15","article-title":"Functionally defined therapeutic targets in diffuse intrinsic pontine glioma","author":"CS Grasso","year":"2015","journal-title":"Nature medicine"},{"issue":"5","key":"ref16","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1002\/cncr.20470","article-title":"Analysis of interleukin-13 receptor \u03b12 expression in human pediatric brain tumors","volume":"101","author":"M Kawakami","year":"2004","journal-title":"Cancer"},{"issue":"5","key":"ref17","first-page":"985","article-title":"Receptor for interleukin 13 is a marker and therapeutic target for human high-grade gliomas","volume":"5","author":"W Debinski","year":"1999","journal-title":"Clinical cancer research: an official journal of the American Association for Cancer Research"},{"issue":"11","key":"ref18","first-page":"1253","article-title":"Human glioma cells overexpress receptors for interleukin 13 and are extremely sensitive to a novel chimeric protein composed of interleukin 13 and pseudomonas exotoxin","volume":"1","author":"W Debinski","year":"1995","journal-title":"Clinical cancer research: an official journal of the American Association for Cancer Research"},{"issue":"20","key":"ref19","doi-asserted-by":"crossref","first-page":"9903","DOI":"10.1158\/0008-5472.CAN-06-4558","article-title":"Interleukin-4 Cytotoxin Therapy Synergizes with Gemcitabine in a Mouse Model of Pancreatic Ductal Adenocarcinoma","volume":"67","author":"T Shimamura","year":"2007","journal-title":"Cancer research"},{"issue":"1","key":"ref20","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.cyto.2015.05.026","article-title":"Targeting of IL-4 and IL-13 receptors for cancer therapy","volume":"75","author":"A Suzuki","year":"2015","journal-title":"Cytokine"},{"issue":"10","key":"ref21","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1093\/neuonc\/nou045","article-title":"Significance of interleukin-13 receptor alpha 2-targeted glioblastoma therapy","volume":"16","author":"B Thaci","year":"2014","journal-title":"Neuro-Oncology"},{"issue":"3\u20134","key":"ref22","first-page":"255","article-title":"An immune regulatory cytokine receptor and glioblastoma multiforme: an unexpected link","volume":"9","author":"W Debinski","year":"1998","journal-title":"Critical reviews in oncogenesis"},{"issue":"7","key":"ref23","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1200\/JCO.2006.08.1117","article-title":"Direct Intracerebral Delivery of Cintredekin Besudotox (IL13-PE38QQR) in Recurrent Malignant Glioma: A Report by the Cintredekin Besudotox Intraparenchymal Study Group","volume":"25","author":"S Kunwar","year":"2007","journal-title":"Journal of Clinical Oncology"},{"issue":"2","key":"ref24","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1124\/jpet.109.154401","article-title":"Convection-Enhanced Drug Delivery of Interleukin-4 Pseudomonas Exotoxin (PRX321): Increased Distribution and Magnetic Resonance Monitoring","volume":"330","author":"Y Mardor","year":"2009","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"issue":"10","key":"ref25","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1111\/ene.12192","article-title":"Defining pseudoprogression in glioblastoma multiforme","volume":"20","author":"E Van Mieghem","year":"2013","journal-title":"European journal of neurology: the official journal of the European Federation of Neurological Societies"},{"issue":"19","key":"ref26","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1200\/JCO.2013.54.0526","article-title":"Antigen-specific immune responses and clinical outcome after vaccination with glioma-associated antigen peptides and polyinosinic-polycytidylic acid stabilized by lysine and carboxymethylcellulose in children with newly diagnosed malignant brainstem and nonbrainstem gliomas","volume":"32","author":"IF Pollack","year":"2014","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"},{"issue":"26","key":"ref27","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1056\/NEJMoa1610497","article-title":"Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy","volume":"375","author":"CE Brown","year":"2016","journal-title":"New England Journal of Medicine"},{"issue":"9","key":"ref28","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1097\/CJI.0b013e318186c8b4","article-title":"A novel CD19-directed recombinant bispecific antibody derivative with enhanced immune effector functions for human leukemic cells","volume":"31","author":"C Kellner","year":"2008","journal-title":"Journal of immunotherapy"},{"issue":"6","key":"ref29","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1002\/ijc.10557","article-title":"Extremely potent, rapid and costimulation-independent cytotoxic T-cell response against lymphoma cells catalyzed by a single-chain bispecific antibody","volume":"100","author":"T Dreier","year":"2002","journal-title":"International journal of cancer Journal international du cancer"},{"issue":"1","key":"ref30","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/2045-3701-4-70","article-title":"Purified anti-CD3 x anti-HER2 bispecific antibody potentiates cytokine-induced killer cells of poor spontaneous cytotoxicity against breast cancer cells","volume":"4","author":"Q He","year":"2014","journal-title":"Cell & bioscience"},{"issue":"19","key":"ref31","doi-asserted-by":"crossref","first-page":"7500","DOI":"10.1158\/0008-5472.CAN-10-2353","article-title":"Epidermal growth factor receptor expression identifies functionally and molecularly distinct tumor-initiating cells in human glioblastoma multiforme and is required for gliomagenesis","volume":"70","author":"S Mazzoleni","year":"2010","journal-title":"Cancer Res"},{"issue":"18","key":"ref32","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1200\/JCO.2009.26.7252","article-title":"Integrated molecular genetic profiling of pediatric high-grade gliomas reveals key differences with the adult disease","volume":"28","author":"BS Paugh","year":"2010","journal-title":"J Clin Oncol"},{"issue":"1","key":"ref33","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/BF02478919","article-title":"Expression of hepatocyte growth factor and matrix metalloproteinase-2 in human glioma","volume":"18","author":"H Yano","year":"2001","journal-title":"Brain Tumor Pathol"},{"issue":"3","key":"ref34","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/ijc.1349","article-title":"Reduced expression of hepatocyte growth factor activator inhibitor type-2\/placental bikunin (HAI-2\/PB) in human glioblastomas: implication for anti-invasive role of HAI-2\/PB in glioblastoma cells","volume":"93","author":"R Hamasuna","year":"2001","journal-title":"Int J Cancer"},{"issue":"30","key":"ref35","doi-asserted-by":"crossref","first-page":"3999","DOI":"10.1200\/JCO.2011.35.5677","article-title":"Genome-wide analyses identify recurrent amplifications of receptor tyrosine kinases and cell-cycle regulatory genes in diffuse intrinsic pontine glioma","volume":"29","author":"BS Paugh","year":"2011","journal-title":"J Clin Oncol"},{"issue":"3","key":"ref36","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1002\/jcp.21544","article-title":"Treatment of Pediatric Brain Tumors","volume":"217","author":"M Karajannis","year":"2008","journal-title":"Journal of cellular physiology"},{"issue":"3","key":"ref37","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/ng.1102","article-title":"Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas","volume":"44","author":"G Wu","year":"2012","journal-title":"Nat Genet"},{"issue":"4","key":"ref38","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/74710","article-title":"Gene therapy of experimental brain tumors using neural progenitor cells","volume":"6","author":"S Benedetti","year":"2000","journal-title":"Nat Med"},{"issue":"7","key":"ref39","doi-asserted-by":"crossref","first-page":"2956","DOI":"10.1158\/0008-5472.CAN-04-3592","article-title":"Aberrant Stat3 signaling by interleukin-4 in malignant glioma cells: involvement of IL-13Ralpha2","volume":"65","author":"SO Rahaman","year":"2005","journal-title":"Cancer research"},{"issue":"5","key":"ref40","first-page":"1168","article-title":"Interleukin-13 receptor alpha chain: a novel tumor-associated transmembrane protein in primary explants of human malignant gliomas","volume":"60","author":"BH Joshi","year":"2000","journal-title":"Cancer research"},{"issue":"18","key":"ref41","doi-asserted-by":"crossref","first-page":"5753","DOI":"10.1158\/1078-0432.CCR-08-3210","article-title":"EGFRvIII deletion mutations in pediatric high-grade glioma and response to targeted therapy in pediatric glioma cell lines","volume":"15","author":"DA Bax","year":"2009","journal-title":"Clinical cancer research: an official journal of the American Association for Cancer Research"},{"issue":"3","key":"ref42","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s11060-012-0842-3","article-title":"Expression of epidermal growth factor variant III (EGFRvIII) in pediatric diffuse intrinsic pontine gliomas","volume":"108","author":"G Li","year":"2012","journal-title":"Journal of neuro-oncology"},{"issue":"5","key":"ref43","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/ng.2938","article-title":"The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma","volume":"46","author":"G Wu","year":"2014","journal-title":"Nature genetics"},{"issue":"11","key":"ref44","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1593\/neo.111016","article-title":"Disclosure of erlotinib as a multikinase inhibitor in pancreatic ductal adenocarcinoma","volume":"13","author":"L Conradt","year":"2011","journal-title":"Neoplasia"},{"issue":"2","key":"ref45","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1158\/0008-5472.379.65.2","article-title":"Cellular targets of gefitinib","volume":"65","author":"D Brehmer","year":"2005","journal-title":"Cancer research"},{"issue":"7406","key":"ref46","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nature11125","article-title":"The mutational landscape of lethal castration-resistant prostate cancer","volume":"487","author":"CS Grasso","year":"2012","journal-title":"Nature"},{"issue":"3","key":"ref47","doi-asserted-by":"crossref","first-page":"R25","DOI":"10.1186\/gb-2009-10-3-r25","article-title":"Ultrafast and memory-efficient alignment of short DNA sequences to the human genome","volume":"10","author":"B Langmead","year":"2009","journal-title":"Genome Biology"},{"issue":"11","key":"ref48","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1593\/neo.111252","article-title":"Detection of Somatic Copy Number Alterations in Cancer Using Targeted Exome Capture Sequencing","volume":"13","author":"RJ Lonigro","year":"2011","journal-title":"Neoplasia (New York, NY)"},{"issue":"7","key":"ref49","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/nmeth.1226","article-title":"Mapping and quantifying mammalian transcriptomes by RNA-Seq","volume":"5","author":"A Mortazavi","year":"2008","journal-title":"Nat Meth"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0193565","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,18]],"date-time":"2022-08-18T05:09:07Z","timestamp":1660799347000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0193565"}},"subtitle":[],"editor":[{"given":"Ilya","family":"Ulasov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,4,5]]},"references-count":49,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2018,4,5]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0193565","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,5]]}}}